Health and Healthcare

Merck : MRK

All Merck Articles

1083 Articles

Chris Lange | Mar 23, 2016 at 9:05 AM EDT

How Ionis Pharma Beat a Biotech Giant

Ionis Pharmaceuticals led biotech stocks early on Wednesday following a key patent dispute win in the U.S. court system.

Chris Lange | Mar 15, 2016 at 9:25 AM EDT

Jefferies Top Drug Stocks for the Rest of 2016

For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made…

Chris Lange | Mar 10, 2016 at 8:40 AM EST

Major Pharma Short Interest Takes a Small Step Back

The February 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Feb 25, 2016 at 8:10 AM EST

Short Sellers Increase Bets in Major Pharma

The February 12 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Chris Lange | Feb 10, 2016 at 9:15 AM EST

Short Sellers Increase Bets in Major Pharma

The January 29 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Jon C. Ogg | Feb 9, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Apple, Freeport-McMoRan, Kinross Gold, Pfizer, Plains All American, Salesforce, Tesla, Yelp and More

The top analyst upgrades, downgrades and initiations seen on Tuesday include Apple, Freeport-McMoRan, Kinross Gold, Pfizer, Plains All American, Salesforce,com,…

Lee Jackson | Feb 8, 2016 at 8:25 AM EST

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

If you ever want to look for value in a sector in the stock market, then when you see Congress…

Chris Lange | Feb 7, 2016 at 10:15 AM EST

How Analysts View Pfizer and Merck After Earnings

After Pfizer and Merck released their most recent earnings reports last week, analysts weighed in on both of these pharmaceutical…

Chris Lange | Feb 3, 2016 at 8:45 AM EST

Merck Trips Up Over Mixed Earnings

Merck reported mixed fourth-quarter financial results before the markets opened Wednesday.

Chris Lange | Jan 31, 2016 at 10:10 AM EST

Top 3 Dow Earnings for the Coming Week

24/7 Wall St. has put together a preview of the three Dow Jones Industrial Average companies that are reporting their…

Jon C. Ogg | Jan 30, 2016 at 10:50 AM EST

5 Dow Stocks Getting Slammed in 2016 Have Not Even Reported Earnings Yet

Some of the Dow stocks that are down in 2016 haven't even reported earnings. This is the market bracing for…

Chris Lange | Jan 28, 2016 at 8:40 AM EST

Short Sellers Become More Selective on Major Pharma

The January 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Paul Ausick | Jan 27, 2016 at 4:01 PM EST

The 4 Stocks That Tanked the Dow on Wednesday

January 27, 2016: Markets opened lower on Wednesday, but a brief morning sojourn into positive territory only lasted until the…

Jon C. Ogg | Jan 27, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Apple, AT&T, DuPont, Fitbit, Huntington Bancshares, McDonald’s, Merck, Newmont, Sprint and More

Wednesday's top analyst calls include Apple, AT&T, DuPont, Fitbit, Huntington Bancshares, McDonald's, Merck, Newmont Mining and Sprint.

Chris Lange | Jan 25, 2016 at 11:35 AM EST

Could This Merck Deal Be the Turning Point for Affimed?

Affimed shares rose on Monday following the announcement of a collaboration in immuno-oncology with biotech giant Merck.

1 … 37 38 39 40 41 … 73

Merck : MRK

All Merck Articles

How Ionis Pharma Beat a Biotech Giant

Jefferies Top Drug Stocks for the Rest of 2016

Major Pharma Short Interest Takes a Small Step Back

Short Sellers Increase Bets in Major Pharma

Short Sellers Increase Bets in Major Pharma

Top Analyst Upgrades and Downgrades: Apple, Freeport-McMoRan, Kinross Gold, Pfizer, Plains All American, Salesforce, Tesla, Yelp and More

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

How Analysts View Pfizer and Merck After Earnings

Merck Trips Up Over Mixed Earnings

Top 3 Dow Earnings for the Coming Week

5 Dow Stocks Getting Slammed in 2016 Have Not Even Reported Earnings Yet

Short Sellers Become More Selective on Major Pharma

The 4 Stocks That Tanked the Dow on Wednesday

Top Analyst Upgrades and Downgrades: Apple, AT&T, DuPont, Fitbit, Huntington Bancshares, McDonald’s, Merck, Newmont, Sprint and More

Could This Merck Deal Be the Turning Point for Affimed?

Want $1,500 a Month in Rent Without a Single 2 a.m. Phone Call? These 3 ETFs Pay You Like a Landlord

Why a $50,000 401(k) Loan at 50 Could Quietly Cost You $100,000 by Retirement

Inflation Subtly Stole 20% of Your Savings Since 2020. These 3 ETFs Hit Back

Why a $50,000 401(k) Loan at 50 Could Quietly Cost You $100,000 by Retirement

Her Husband Handled the Medicare Paperwork. After He Died, Her Premium Doubled Overnight.

Want $1,500 a Month in Rent Without a Single 2 a.m. Phone Call? These 3 ETFs Pay You Like a Landlord

Why a $50,000 401(k) Loan at 50 Could Quietly Cost You $100,000 by Retirement

Merck : MRK

All Merck Articles

How Ionis Pharma Beat a Biotech Giant

Jefferies Top Drug Stocks for the Rest of 2016

Major Pharma Short Interest Takes a Small Step Back

Short Sellers Increase Bets in Major Pharma

Short Sellers Increase Bets in Major Pharma

Top Analyst Upgrades and Downgrades: Apple, Freeport-McMoRan, Kinross Gold, Pfizer, Plains All American, Salesforce, Tesla, Yelp and More

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

How Analysts View Pfizer and Merck After Earnings

Merck Trips Up Over Mixed Earnings

Top 3 Dow Earnings for the Coming Week

5 Dow Stocks Getting Slammed in 2016 Have Not Even Reported Earnings Yet

Short Sellers Become More Selective on Major Pharma

The 4 Stocks That Tanked the Dow on Wednesday

Top Analyst Upgrades and Downgrades: Apple, AT&T, DuPont, Fitbit, Huntington Bancshares, McDonald’s, Merck, Newmont, Sprint and More

Could This Merck Deal Be the Turning Point for Affimed?

Want $1,500 a Month in Rent Without a Single 2 a.m. Phone Call? These 3 ETFs Pay You Like a Landlord

Why a $50,000 401(k) Loan at 50 Could Quietly Cost You $100,000 by Retirement

Inflation Subtly Stole 20% of Your Savings Since 2020. These 3 ETFs Hit Back

Featured Reads

Why a $50,000 401(k) Loan at 50 Could Quietly Cost You $100,000 by Retirement

Her Husband Handled the Medicare Paperwork. After He Died, Her Premium Doubled Overnight.